Curt Engelhorn & family Net Worth

6 months from now

Curt Engelhorn was a German billionaire, pharmaceutical business leader and great-grandson of the founder of BASF. After studying chemical engineering in Texas after World War II, he took the helm of a small family business, Boehringer Mannheim, and expanded its biochemical and pharmaceutical operations. In 1997, he sold the company to Roche for $11 billion, walking away with an estimated $4.1 billion. His philanthropic activities included sponsoring disease research and the Heidelberg Center for American Studies at the University of Heidelberg. He passed away in October 2016 at age 90, survived by his fourth wife and five children. His family made news in 2016 when it was revealed that two of his daughters had not paid taxes on real estate and money they had been given by their father, and they agreed to a deal with German authorities to repay taxes and fines in the amount of about $155 million.
Curt Engelhorn & family is a member of Health care

Age, Biography and Wiki

Birth Day	May 25, 1926
Birth Place	Germany
Age	94 YEARS OLD
Died On	13 October 2016(2016-10-13) (aged 90)
Birth Sign	Gemini
Residence	Gstaad, Switzerland
Alma mater	University of Texas at Austin
Known for	Former owner, Boehringer Mannheim and DePuy Inc.
Children	5
Relatives	Friedrich Engelhorn (great-grandfather)

💰 Net worth: $6.2 Billion (2024)

Curt Engelhorn & family, a prominent name associated with the healthcare sector in Germany, holds an estimated net worth of $6.2 billion as of 2024. With a long-standing history of contributions in the healthcare industry, the Engelhorn family has solidified their position as successful entrepreneurs in Germany. Their substantial wealth is a result of their investments and involvement in various healthcare ventures, showcasing their deep understanding and commitment to this crucial sector. With their vast fortune, the Engelhorn family continues to create a positive impact on healthcare and further solidifies their role as trusted contributors to the well-being of the nation.

2010 $6.3 Billion

2011 $6.6 Billion

2012 $6.6 Billion

2013 $4 Billion

2014 $4 Billion

2015 $6.2 Billion

2016 $6.2 Billion

2018 $6.2 Billion

Biography/Timeline

1997

For more than three and a half decades, Engelhorn led the pharmaceutical companies Boehringer Mannheim and DePuy Inc. In 1997 he sold the two firms (in which together he had a 40% stake) to Hoffmann-La Roche for more than $10 billion.

2008

In 2008 it was announced that Engelhorn would be donating Euro 400,000 annually over the period of 10 years to support American studies at the Heidelberg Center for American Studies.

2012

In 2012 it was discovered that an authentic 12th century cloister had been used as a pool decoration in one of Engelhorn's Spanish estates, hidden from the public and the Spanish conservation authorities for more than half a century.

2013

Since late 2013, there have been ongoing investigations by the German authorities concerning suspected tax frauds between Engelhorn and his daughters, avoiding capital transfer taxes of up to Euro 440 million (US$475 million). As of January 2016, the family's lawyers conceded capital transfer tax evasions in the amount of Euro 135 million (US $145 million) to the court.

2016

As of June 2015, according to Forbes, Engelhorn had a net worth of $6.2 billion. He died on 13 October 2016, aged 90.